HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Yi Huang Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

9/2010The nonpeptide AVE0991 attenuates myocardial hypertrophy as induced by angiotensin II through downregulation of transforming growth factor-beta1/Smad2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Yi Huang Research Topics

Disease

2Hypertrophy
09/2010 - 03/2010
1Ischemia
11/2011
1Hypoxia (Hypoxemia)
11/2011
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2011
1Cardiovascular Diseases (Cardiovascular Disease)
09/2010
1Myocardial Infarction
03/2010
1Cardiomegaly (Heart Hypertrophy)
03/2010

Drug/Important Bio-Agent (IBA)

2Brain Natriuretic Peptide (Natrecor)FDA Link
11/2011 - 03/2010
2Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2010 - 03/2010
1Glucose (Dextrose)FDA LinkGeneric
11/2011
1Interleukin-6 (Interleukin 6)IBA
11/2011
1CytokinesIBA
11/2011
1AVE 0991IBA
09/2010
1Angiotensin IIIBA
09/2010
1Transforming Growth Factors (Transforming Growth Factor)IBA
03/2010
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
03/2010
1AngiotensinsIBA
03/2010
1KT 5823IBA
03/2010

Therapy/Procedure

1Aftercare (After-Treatment)
03/2010
1Ligation
03/2010